{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:47:45Z","timestamp":1778816865696,"version":"3.51.4"},"reference-count":39,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2003,2,13]],"date-time":"2003-02-13T00:00:00Z","timestamp":1045094400000},"content-version":"vor","delay-in-days":1565,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[1998,11]]},"abstract":"<jats:p>Eight patients with parkinsonism who developed severe orthostatic sypotension, were treated with oral ergotamine\/caffeine. Significant long\u2010term improvement in standing systolic blood pressure and symptoms of syncope and light\u2010headedness were observed in four of these patients. One patient in whom the drug was effective discontinued it because of nausea. Another lost benefit after 2 weeks of sucessful therapy. Significant supine systolic hypertension occureed in only one patient, which was easily managed by nifedipine given at night. Symptoms or signs of ergotism were not observed. Oral ergotamine\/caffeine should be considered as a cost\u2010effective teratment for refactory orthostatic hypotension in carefully selected patients with parkinsonism.<\/jats:p>","DOI":"10.1046\/j.1468-1331.1998.560593.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T19:34:27Z","timestamp":1047411267000},"page":"593-599","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Ergotamine\/caffeine treatment of orthostatic hypotension in parkinsonism with autonomic failure"],"prefix":"10.1111","volume":"5","author":[{"suffix":"Jr","given":"Richard B.","family":"Dewey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surendra D.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie L.","family":"Holmburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald G.","family":"Victor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,2,13]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199310000-00024"},{"key":"e_1_2_1_3_1","first-page":"560","article-title":"Ergotamine, methysergide, and carcinoidinduced endocardial lesions [letter]","volume":"114","author":"Bates HR","year":"1990","journal-title":"Arth Pathol Laboratory Med"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(90)90031-U"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","DOI":"10.1080\/00325481.1986.11699500","article-title":"Brachial artery stenosis secondary to ergotism and responsive to nifedipine","volume":"80","author":"Borges AA","year":"1986","journal-title":"Postgraduate Med"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(81)90049-1"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.67.3.602"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110516"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-198612000-00005"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(95)02104-Z"},{"key":"e_1_2_1_11_1","first-page":"296","article-title":"Dihydroergotamine in idiopathic orthostatic hypotension: short\u2010term intramuscular and long\u2010term oral therapy","volume":"14","author":"Found FM","year":"1981","journal-title":"Clin Neuropharmacol"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199108000-00002"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)92469-4"},{"key":"e_1_2_1_14_1","first-page":"125","article-title":"Midodrine in neurogenic orthostatic hypotension. A new treatment [review]","volume":"12","author":"Gilden JL","year":"1993","journal-title":"International Angiol"},{"key":"e_1_2_1_15_1","article-title":"Prenalterol in the treatment of orthostatic hypotension in Shy\u2010Drager syndrome","volume":"39","author":"Goovaerts J","year":"1984","journal-title":"Acta Cardiol"},{"key":"e_1_2_1_16_1","first-page":"56","article-title":"Orthostatic hypotension after spinal cord injury: treatment with fludrocortisone and ergotamine","volume":"72","author":"Groomes TE","year":"1991","journal-title":"Arch Phys Med Rehabilitation."},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(94)90304-2"},{"key":"e_1_2_1_18_1","article-title":"Mitral and aortic valve disease associated with ergotamine therapy for migraine. Report of two cases and review of literture","volume":"114","author":"Hauck AJ","year":"1990","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-105-2-168"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90230-M"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6185.307"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.6.951"},{"key":"e_1_2_1_23_1","article-title":"Treatment of idiopathic orthostatic hypotension (Shy Drager syndrome) with indomethacin","volume":"1","author":"Kochar MS","year":"1978","journal-title":"Lancet"},{"key":"e_1_2_1_24_1","first-page":"106","article-title":"Dihydroergotamine (Dihydergot) in the treatment of orthostatic circulatory idsorders: a double blind comparison with placebo","volume":"4","author":"Kruger K","year":"1973","journal-title":"J Med"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-109-3-249_1"},{"key":"e_1_2_1_26_1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000169827","article-title":"A controlled study with Dihydergot on patients with orthostatic dysregulation","volume":"61","author":"Lubke KO","year":"1976","journal-title":"Cardiol"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)91509-9"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(81)90641-3"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/000331979504600712"},{"key":"e_1_2_1_30_1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0733-8619(18)31086-7","article-title":"Multiple system atrophy. Clinical aspects, pathophysiology, and treatment","volume":"2","author":"Polinsky RJ","year":"1984","journal-title":"Neurol Clin"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199306000-00003"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(83)90607-1"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198908000-00034"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1159\/000115820"},{"key":"e_1_2_1_35_1","article-title":"Midodrine. A new agent in the management of idiopathic orthostatic hypotension and Shy\u2010Drager syndrome","volume":"56","author":"Schirger A","year":"1981","journal-title":"Mayo Clinic proceed"},{"key":"e_1_2_1_36_1","article-title":"A neurological syndrome associated with orthostatic hypotension","volume":"2","author":"Shy GM","year":"1960","journal-title":"Arch Neurol"},{"key":"e_1_2_1_37_1","article-title":"Treatment of postural hypotension with aerosol ergotamine","volume":"139","author":"Siminoski K","year":"1988","journal-title":"Can Med Association J"},{"key":"e_1_2_1_38_1","doi-asserted-by":"crossref","DOI":"10.1080\/00325481.1989.11700537","article-title":"Ergotism masquerading as arteritis","volume":"85","author":"Tarnower A","year":"1989","journal-title":"Postgraduate Med"},{"key":"e_1_2_1_39_1","article-title":"Xamoterol in the treatment of orthostatic hypotension associated with multiple system atrophy (Shy\u2010Drager syndrome)","volume":"74","author":"West JN","year":"1990","journal-title":"Q J Med"},{"key":"e_1_2_1_40_1","article-title":"Pharmacodynamics of midodrine an antihypotensive agent","volume":"39","author":"Zachariah PK","year":"1986","journal-title":"Clinl Pharmacol Therapeutics"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1468-1331.1998.560593.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1468-1331.1998.560593.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T20:05:33Z","timestamp":1698523533000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1468-1331.1998.560593.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1998,11]]}},"alternative-id":["10.1046\/j.1468-1331.1998.560593.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1468-1331.1998.560593.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,11]]},"assertion":[{"value":"2003-02-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}